Potentiation of anti-aggregating activity of PGI2 by 7-ethoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1(2H)-phthalazinone (EG-626) in rabbit platelets in vitro

This publication has 11 references indexed in Scilit:

• Non-specific antagonism against thromboxane A2 of 7-ethoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1(2H)-phthalazinone (EG-626) in contraction of isolated smooth muscles
  Prostaglandins, 1979
• EG-626: Not a thromboxane A2 antagonist, but a PGI2 potentiator in platelet aggregation
  Prostaglandins, 1979
• Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species
  Prostaglandins, 1978
• DIPYRIDAMOLE AND OTHER PHOSPHODIESTERASE INHIBITORS ACT AS ANTITHROMBOTIC AGENTS BY POTENTIATING ENDOGENOUS PROSTACYCLIN
  The Lancet, 1978
• De-aggregatory action of prostacyclin and its enhancement by theophylline
  Prostaglandins, 1978
• An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue
  Biochemical Medicine, 1977
• Phosphodiesterase Inhibitors: Their Comparative Effectiveness in Vitro in Various Organs
  The Japanese Journal of Pharmacology, 1977
• Hyperreactive Arterial Endothelial Cells in Atherogenesis and Cyclic AMP Phosphodiesterase Inhibitor in Prevention and Treatment of Atherosclerotic Disorders
  Japanese Heart Journal, 1975
• Platelet aggregation IV. Platelet phosphodiesterase and its inhibition by vasodilators
  Biochemical and Biophysical Research Communications, 1971
• EFFECT OF DIPYRIDAMOLE ON HUMAN PLATELET BEHAVIOUR
  The Lancet, 1965